Monoprost
Monoprost is a medicine authorised by Swissmedic under authorisation number 66858. The authorisation holder is THEA Pharma S.A.. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 April 2018 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 66858 |
|---|---|
| Name | Monoprost |
| Full name | Monoprost, collyre en solution |
| Authorisation holder | THEA Pharma S.A. |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 19 April 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Monoprost, collyre en solution | B | 19 April 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Monoprost authorised in Switzerland?
Yes. Monoprost is authorised by Swissmedic under authorisation number 66858, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Monoprost have?
Monoprost is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Monoprost?
The authorisation holder is THEA Pharma S.A.. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.